*Level of evidence: Strong=multiple randomised clinical trials or meta-analyses; Medium=single randomised or large non-randomised trials; Weak=retrospective studies, registry data, or small studies and/or consensus of expert opinion.

†References are American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) guidelines for stable coronary artery disease.

Reference 1: Fihn S, Gardin J, Abrams J, et al. 2012 ACCF/AHA/AATS/PCNA/SCAI/STS Guideline for the  diagnosis and  management of patients with stable ischaemic heart disease. J Am Coll Cardiol 2012;60:e44-164.

Reference 2: Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC Guidelines on the management of stable coronary artery disease. Eur Heart J 2013;34:2949-3003.